The observation of similar findings upon treatment with GPR55 agonist LPI and attenuation of its effects by CBD and CID strongly support the conclusion that the decreased Ki67+ fractions detected in GBM #4 and GBM #10 upon THC treatment were mainly driven by the activation of GPR55 (Figure 8). This evidence concerns the gene GPR55 and glioblastoma.